drugset

drugset / Trial / NCT01435200

Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

NCT01435200 ↗

Phase 3 Completed 64 enrolled Chulalongkorn University

RandomizedParallel-groupOpen-labelTreatment

Summary

Can intravenous iron lower the rate of blood transfusion in gynecologic cancer patients receiving platinum based chemotherapy than oral iron?

Timeline

Start: 2011-06
Primary completion: 2012-10
Completion: 2012-11

Publications

Athibovonsuk P, Manchana T, Sirisabya N. Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol. 2013 Dec;131(3):679-82. doi: 10.1016/j.ygyno.2013.09.028. Epub 2013 Oct 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Iron sucrose	Unknown	200 mg	Intravenous

Indications